Suppr超能文献

他达拉非对大鼠肾缺血再灌注损伤的有益作用。

The beneficial effects of tadalafil on renal ischemia-reperfusion injury in rats.

作者信息

Guzeloglu Mehmet, Yalcinkaya Fatih, Atmaca Soner, Bagriyanik Alper, Oktar Suleyman, Yuksel Oguz, Fansa Iyad, Hazan Eyup

机构信息

Department of Cardiovascular Surgery, Tayfur Ata Sokmen Medical Faculty, Mustafa Kemal University, Hatay, Turkey. mehmetguzeloglu @ hotmail.com

出版信息

Urol Int. 2011;86(2):197-203. doi: 10.1159/000321927. Epub 2010 Dec 16.

Abstract

Acute renal failure due to ischemia-reperfusion (I/R) injury is a common complication in cardiovascular surgery. We determined the influence of tadalafil on renal injury in a renal I/R model in rats. For this purpose, 21 male Wistar albino rats were separated into 3 groups: sham, placebo and tadalafil. A right nephrectomy was performed, and the left renal pedicles were occluded for 60 min and reperfused for 60 min in the placebo and tadalafil groups. A single dose of tadalafil (10 mg/kg) through an orogastric tube was administered to the tadalafil group. Tubular atrophy with acute inflammation in renal histology, total oxidant status (TOS) and total antioxidant status (TAS) were determined in tissue homogenates. Compared to the tadalafil group, tubular atrophy and acute inflammation was significant in the placebo group. TAS levels were significantly higher in the tadalafil group compared to the placebo (p = 0.01) and sham groups (p = 0.04). While TOS levels were significantly higher in the placebo group (p = 0.03), tadalafil did not significantly alter the TOS levels. The beneficial effects of tadalafil can be attributed to its protective effects on renal tubular cells and inhibition of leukocyte infiltration in renal tissue. We think that tadalafil treatment has an important role in reducing renal injury resulting from renal I/R.

摘要

缺血再灌注(I/R)损伤所致急性肾衰竭是心血管手术中常见的并发症。我们在大鼠肾I/R模型中确定了他达拉非对肾损伤的影响。为此,将21只雄性Wistar白化大鼠分为3组:假手术组、安慰剂组和他达拉非组。在安慰剂组和他达拉非组中,进行右肾切除术,左肾蒂阻断60分钟,再灌注60分钟。通过胃管给他达拉非组大鼠单次给予他达拉非(10mg/kg)。测定组织匀浆中肾组织学中的肾小管萎缩伴急性炎症、总氧化状态(TOS)和总抗氧化状态(TAS)。与他达拉非组相比,安慰剂组肾小管萎缩和急性炎症明显。与安慰剂组(p = 0.01)和假手术组(p = 0.04)相比,他达拉非组的TAS水平显著更高。虽然安慰剂组的TOS水平显著更高(p = 0.03),但他达拉非并未显著改变TOS水平。他达拉非的有益作用可归因于其对肾小管细胞的保护作用以及对肾组织中白细胞浸润的抑制作用。我们认为他达拉非治疗在减轻肾I/R所致肾损伤方面具有重要作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验